The changes in the signalling and functional effects of novel intracellular immune checkpoint receptors LAG-3, TIGIT and TIM-3, following blockade by ICIs in HNSCC are shown in Figure 3B. Here, HAVCR2 is linked to head and neck squamous cell carcinoma.